Abstract:C omplete tumor resection is of utmost importance and a cornerstone in the treatment of numerous tumors; it is the aim of every surgeon. Surgery might be followed by adjuvant therapy to complete this task, but it still may fail as a result of limited recognition of tumor cells at the resection site. An incomplete tumor resection is at risk of tumor recurrence regardless of adjuvant therapies, and recurrence decreases quality of life and shortens life expectancy. Tumor diagnosis and intraoperative definition of tumor borders are based on various visualization methods and on the histopathological examination of a limited number of biopsy specimens via frozen sections. Today, gold standard surgical visualization tools include surgical “microscopes,” laparoscopes, ultrasonography, intraoperative magnetic resonance imaging, and computed tomography, as well as more sophisticated navigation devices. None of these is able to differentiate tumor from normal tissue at a cellular level, which is necessary to achieve higher accuracy in surgical tumor therapy, especially for malignant tumors. Therefore, frozen sections are typically used to define and differentiate tumor cells ex vivo. Normally, they are removed when the tumor is exposed but not yet resected. Unfortunately, intraoperative histopathology has several shortcomings, and many biopsies are inconclusive. First, the tissue architecture of the tumor can be altered during specimen preparation and can be mechanically destroyed. In addition, sampling errors are possible as a result of tissue heterogeneity. Finally, the lack of realtime interactivity with the pathologist and the waiting time of about 30 minutes for the result disrupt the surgical workflow. According to our own surgical experiences, we can say that optimal surgical therapy includes a combination of maximal resection of diseased tissue with minimal damage to the normal tissue. This can be achieved only with the ability to identify intraoperative cellular structures and to differentiate tumor from normal functional tissue. This opinion assumes the need for new technological equipment integrated within new surgical concepts. Confocal laser endomicroscopy (CLE) is an imaging technique that provides microscopic information of tissue in real time. Instead of taking a tissue sample from a patient and bringing it under the microscope for analysis, these “optical biopsies” bring the microscope inside the patient through miniaturized fiberoptic probes and allow real-time histopathology with a resolution down to 1 mm. A clear visualization of the cytoarchitecture of the cell can be achieved with a 1000fold magnification. CLE was introduced in 2004 in gastroenterology as a supplement to the current standard endoscopy for performing optical biopsies. It is also currently becoming a useful diagnostic tool in urology, pulmonology, and gynecology. We investigated the use of CLE in our neurosurgical treatment to analyze the technical considerations. Furthermore, we investigated the integration of CLE in the neurosurgical daily workflow in the operation room as an ex vivo diagnostic module, and we tried to create an easy integration of the CLE technique into the neurosurgical daily routine using endoscopic or microscopic settings and providing immediate intraoperative histopathological diagnosis of the entire entity in real time.We also investigated the best conditions for an evaluation of CLE for in vivo diagnosis in different types and models of intracranial and intraspinal neoplasia. Our results are reported here.

Confocal laser endomicroscopy in pathological classifications of gastric cancer in vivo

The real time pathological diagnosis value of confocal laser endomicroscopy in gastric cancer and precancerous disease

The Diagnostic Accuracy of Conventional Forceps Biopsy Compared to ESD.

Diagnosis of poorly differentiated adenocarcinoma of the stomach by confocal laser endomicroscopy: A case report

Confocal laser endomicroscopy for gastric neoplasm

Confocal Laser Endomicroscopy for the Diagnosis of Colorectal Cancer in Vivo.

Diagnostic Value of Confocal Laser Endomicroscopy for Non-Protruding Gastric Lesions

Confocal Laser Endomicroscopy Can Improve the Diagnosis Rate and Range Assessment of Patients with Conflicting Chronic Atrophic Gastritis Results of White Light Endoscopic and Pathological Diagnosis

Confocal Laser Endomicroscopy for Detection of Early Upper Gastrointestinal Cancer

Confocal Laser Endomicroscopy under Propofol‐based Sedation for Early Gastric Cancer and Pre‐cancerous Lesions is Associated with Better Diagnostic Accuracy: a Retrospective Cohort Study in China

Comparison Between Confocal Laser Endomicroscopy and Gastric Biopsy for Diagnosis of Early Gastric Cancer and Precancerous Disease

Value of Magnifying Endoscopy with Narrow-Band Imaging and Confocal Laser Endomicroscopy in Detecting Gastric Cancerous Lesions.

Diagnostic Performance of Confocal Laser Endomicroscopy for Atrophy and Gastric Intestinal Metaplasia: A Meta-Analysis

Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancer

Optical Biopsy of Bladder Cancer Using Confocal Laser Endomicroscopy

Confocal laser endomicroscopy in gastrointestinal and pancreatobiliary diseases

Value of Confocal Laser Endomicroscopy for Diagnosis of Residual and Recurrent Lesions after Endoscopic Submucosal Dissection

The accuracy of probe-based confocal endomicroscopy versus conventional endoscopic biopsies for the diagnosis of superficial gastric neoplasia (with videos)

Evaluation of confocal laser endomicroscopy on pathological changes of intestinal mucosa repairing for patients with ulcerative colitis

A preliminary study of dual-band confocal laser endomicroscopy combined with image mosaic in the diagnosis of liver cancer

Confocal Laser Endomicroscopy for Real-time Histomorphological Diagnosis: Our Clinical Experience With 150 Brain and Spinal Tumor Cases.